The cost and value of cancer drugs – are new innovations outpacing our ability to pay?

Cancer drug expenditures have been increasing significantly in countries around the world. A recent IJHPR article provides new knowledge and insights into this global phenomenon by analyzing how it is playing out in an Israeli health plan with over two million members, whose state-of-the-art information systems provide an opportunity to explore these changes in a comprehensive, detailed and reliable manner. Read more

A related IJHPR commentary notes that there will be many challenges ahead with regard to the ability to pay for the arrival of new and exciting cancer therapies. The commentary discusses the current problems and anticipates the future challenges. Read more


View all articles

View all articles

Aims and scope

Israel Journal of Health Policy Research seeks to promote intensive intellectual interactions among scholars and practitioners from Israel and other countries regarding all aspects of health policy, health services research, public health, health promotion, health economics, health care management, and the ethics, sociology, and political science of health care in Israel.  The ultimate aim of these intellectual interactions is to contribute to the development of health policy in Israel and around the world.

Society affiliation

Israel Journal of Health Policy Research is the official publication of The Israel National Institute for Health Policy and Health Services Research.

The Israel National Institute for Health Policy and Health Services Research covers article processing charges for all articles accepted for publication.